LEQEMBI Alzheimer’s Treatment Gets FDA Go Ahead
Phase 2 data showing a reduction in amyloid-beta plaques in early Alzheimer's patients is good enough for FDA to give it temporary approval under their Accelerated Approval pathway.
More reads
Putin - Doesn't Want Nuclear War - Aims For Peace & Renewed START 2 With Updated Credible Deterrent
I’ve had several PM’s and we’ve had comments by scared people in our Doomsday Debunked Facebook group who have read alarmist stories suggesting that Putin threatens to attack the US. If you have read…
Why Is A Non-Browning Apple Less 'Natural' Than Non-Fat Milk?
Once upon a time, non-fat milk (the cream removed) was only used for fattening pigs. It was clearly a technological process to remove the cream but it is not considered "unnatural" - in 2012, the…
Nitrate-Reducing Microbes Linked To Migraine Headaches
Researchers have found an association between migraines and microbes that reduce nitrates. Analyzing data from the American Gut Project, they found that migraine sufferers harbored significantly more…